Biotechnology Applications and Innovative Approaches for Cancer Prevention and Treatment (BIO-APP)

Dear Colleagues,

Novel approaches within the field of biochemistry are constantly evolving, particularly in their application to biotechnologies and theranostics. Over the next few years, the healthcare landscape is going to be shaped by innovative approaches to new Point-of-Care technologies, including biosensors and lab-on-a-chip devices, which are not only useful for improving basic research studies but can also help to translate this knowledge into clinical research. Biotechnology-based approaches for nanomaterial functionalization have been exploited to obtain nanomaterials with targeted or multitargeted ligands, monoclonal antibodies, and modified nucleic acids or peptides to increase sensitivity and specificity. Stimuli-responsive or functionalized entities tailored to recognize and interact with specific tumor biomarkers, serving both as sensors for early-stage diagnosis and care tools, are currently being investigated and integrated into biosensing platforms. The rational design of integrating drug delivery and biosensing properties into a single nanomaterial could become an innovative solution for cancer prevention and treatment.

This Special Issue serves to highlight and capture the contemporary progress and current landscape of emerging biotechnologies for cancer research. We invite articles on all aspects of applied biochemistry, biotechnologies, nanomaterials, and innovative platforms for both theranostics and therapeutic strategies development to contribute to identifying novel biomarkers for the early and timely diagnosis of cancers.

Prof. Dr. Luca Vanella
Prof. Dr. Antonino Mazzaglia
Dr. Giuseppe Nocito
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• applied biochemistry
• biotechnologies
• cancer
• drug delivery
• multitarget ligands
• theranostics
• biomarkers
• point-of-care testing
• sensitive nanomaterials